PUBLISHER: The Business Research Company | PRODUCT CODE: 1949670
PUBLISHER: The Business Research Company | PRODUCT CODE: 1949670
Pharmaceutical supply chain management involves the planning, implementation, and control of pharmaceutical products' flow and associated information from manufacturers to end-users. It ensures secure distribution of pharmaceuticals while upholding product quality, safety, and adherence to regulatory standards.
The primary elements of pharmaceutical supply chain management consist of solutions and services. A solution denotes a product, service, or strategic method crafted to tackle particular challenges encountered by pharmaceutical companies through a blend of resources, expertise, or technology. Different deployment options include on-premise and cloud-based models, which serve diverse end-users like healthcare manufacturers, healthcare providers, distributors, and logistics providers.
Tariffs have impacted the pharmaceutical supply chain management market by increasing the cost of imported raw materials, packaging, and logistics equipment, thereby affecting the overall supply chain efficiency. High tariffs have particularly affected pharmaceutical manufacturers and distributors in regions heavily reliant on imports, such as north america and europe. Cold chain solutions and inventory management systems are among the most impacted segments due to higher operational costs. However, tariffs have also encouraged local sourcing and investment in domestic manufacturing, potentially improving long-term supply chain resilience.
The pharmaceutical supply chain management market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain management market statistics, including pharmaceutical supply chain management industry global market size, regional shares, competitors with a pharmaceutical supply chain management market share, detailed pharmaceutical supply chain management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain management industry. This pharmaceutical supply chain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical supply chain management market size has grown strongly in recent years. It will grow from $2.85 billion in 2025 to $3.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to growing pharmaceutical manufacturing, expansion of healthcare facilities, increasing demand for safe drug distribution, adoption of ERP systems, rise in generic drug production.
The pharmaceutical supply chain management market size is expected to see strong growth in the next few years. It will grow to $4.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of ai in supply chain, adoption of predictive analytics, expansion of biologics and vaccines, growth in personalized medicine, increased demand for end-to-end track and trace solutions. Major trends in the forecast period include cold chain optimization, regulatory compliance automation, real-time inventory visibility, vendor and supplier collaboration, risk management in pharmaceutical distribution.
The increasing incidence of chronic diseases is anticipated to fuel expansion in the pharmaceutical supply chain management market. Chronic diseases are enduring health conditions like diabetes, hypertension, and cardiovascular issues that demand sustained treatment, ongoing medication, and frequent medical oversight. This surge stems from aging demographics, lifestyle-induced risks, and growing metabolic conditions. Pharmaceutical supply chain management aids patient outcomes by guaranteeing steady medication availability, avoiding shortages, and enhancing drug delivery for prolonged therapies. For example, in June 2024, the National Health Service-a UK government agency-reported that 3,615,330 patients registered with a general practitioner (GP) had non-diabetic hyperglycemia or pre-diabetes (elevated blood sugar not reaching diabetes levels) in 2023, up 18% from 3,065,825 cases the prior year. Thus, the growing burden of chronic diseases is propelling the pharmaceutical supply chain management market forward.
Major companies in the pharmaceutical supply chain management market are prioritizing the creation of cutting-edge solutions, like temperature-controlled logistics platforms, to address the growing need for secure, streamlined, and regulation-compliant management of delicate pharmaceutical goods. These platforms combine sophisticated cold chain technologies, live temperature tracking, and forecasting analytics to guarantee that medications, vaccines, and biologics stay within required temperature thresholds during storage and transport, minimizing waste and upholding compliance standards. For example, in August 2025, Celcius Logistics Pvt. Ltd., an India-based firm specializing in logistics and supply chains, introduced Celcius+, a state-of-the-art cold chain service tailored for pharmaceuticals. Celcius+ employs IoT sensors, AI-powered path optimization, and cloud monitoring to sustain exact temperature levels throughout the supply chain, preserving drug effectiveness and safety from production to end-user delivery. The service also delivers instant notifications, comprehensive compliance documentation, and flexible scaling for different shipment sizes, catering to both modest and extensive pharmaceutical needs.
In November 2025, DHL Group, a Germany-based contract logistics company, acquired SDS Rx for an undisclosed sum. Through this acquisition, DHL seeks to bolster its life sciences and healthcare logistics platform by incorporating specialized final-mile delivery and time-critical transportation services. Strategic Delivery Solutions LLC is a US-based healthcare logistics provider that focuses on final-mile delivery and high-touch transportation for long-term care and specialty pharmacies.
Major companies operating in the pharmaceutical supply chain management market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc., Oracle Corporation, SAP SE, DSV Panalpina, UPS Healthcare, Parexel International Corporation, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Vetter Pharma International GmbH, Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Jump Technologies, Chain.io Inc.
Asia-Pacific was the largest region in the pharmaceutical supply chain management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmaceutical supply chain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceutical supply chain management market includes revenues earned by entities by providing services such as logistics and distribution, cold chain management, inventory management, and quality control and assurance services that are used to optimize the pharmaceutical supply chain for the delivery of vital medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pharmaceutical supply chain management market consists of sales of cold chain equipment, warehouse automation systems, and automated guided vehicles. to provide pharmaceutical companies with opportunities to optimize the supply chain operations of pharmaceutical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Supply Chain Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmaceutical supply chain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical supply chain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical supply chain management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.